News regarding Oslo Cancer Cluster Incubator

Join NOME – Nordic mentoring programme for life sciences companies

NOME is the first Nordic mentor network connecting prospective life science entrepreneurs with handpicked international mentors.

The goal is simple: to help the very best biotech and medtech startups in the Nordics to become the next growth successes. Oslo Cancer Cluster Incubator coordinates the NOME-programme in Norway and collaborates with Oslo Medtech and the incubator Aleap to find the best match of mentors and entrepreneurs.

 

Watch the NOME information video here

Contact Bjørn Klem, General Manager of Oslo Cancer Cluster Incubator, if you would like to join NOME or if you want more information about the programme in Norway.

Take a look at the NOME website and the information flyer for more information about the programme. 

 

The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway

The PCI Biotech and Ultimovacs collaboration awarded NOK 500,000 from Innovation Norway

Oslo (Norway), 6 January 2017 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and Ultimovacs, a pharmaceutical company developing novel immunotherapy against cancer, today announced that they are awarded NOK 500,000 for further development of the existing preclinical research collaboration. The purpose of the collaboration is to utilise the companies’ complementary scientific platforms to explore potential synergies and the grant will support these activities. The Innovation Norway grant of NOK 500,000 is awarded for 2017 and the grant is made available through Oslo Cancer Cluster a Norwegian Centre of Expertise.

Contact information:
PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo, Norway. www.pcibiotech.com
Per Walday, CEO, pw@pcibiotech.no, Mobile: +47 917 93 429.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.